Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02185872 · ClinicalTrials.gov registry record · NA
CrossFit Exercise to Improve Glucose Control for Overweight and Obese Adults
A NA study of Hyperglycemia, sponsored by Kansas State University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT02185872: Completed NA study of Hyperglycemia, sponsored by Kansas State University.
NCT02185872 is a NA study of Hyperglycemia that has completed, run by Kansas State University. The registered enrollment target is 23 participants, below the 878-participant average among 38 other Hyperglycemia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02185872, a NA study of Hyperglycemia, has completed, sponsored by Kansas State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to examine the differences in glucose control, fitness, and body composition between a standard aerobic and resistance exercise training program and a shorter-duration, high-intensity CrossFit training program in overweight and obese physically inactive adults. Hypotheses: 1. Both groups would improve glucose control, with the CrossFit group improving significantly more than the aerobic and resistance training group. 2. Both groups would improve fitness, with the CrossFit group improving significantly more than the aerobic and resistance training group. 3. Both groups would demonstrate decreases in body fat percentage and fat mass and increases in lean body mass, with the CrossFit group improving significantly more than the aerobic and resistance training group.
Primary Outcome
Fasting plasma glucose levels were taken after an overnight fast of at least 8 hours. An oral glucose tolerance test was conducted after ingestion of a 75g oral dextrose solution with finger sticks at 30, 45, and 60 minutes from time 0. The following equation was used to calculate glucose area under the curve which was the metric utilized to ascertain changes in glucose control: \[(Time 45 - Time 30) \* ½ (OGTT 30 + OGTT 45)\] + \[(Time 60 - Time 45) \* ½ (OGTT 60 + OGTT 45)\]
Conditions Studied
Interventions
- OTHER High-Intensity Functional Training
- OTHER Aerobic and Resistance Training
Study Locations (1)
Kansas
- Kansas State University - Manhattan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-05 |
| Phase | NA |
What the finished NCT02185872 record still lists
NCT02185872 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 878-participant average among 38 other Hyperglycemia trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Hyperglycemia appearing as the primary indexed condition, and to 2 interventions - of which High-Intensity Functional Training is the first listed.
NCT02185872 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT02185872 about?
NCT02185872 is a clinical study titled "CrossFit Exercise to Improve Glucose Control for Overweight and Obese Adults". The purpose of this study was to examine the differences in glucose control, fitness, and body composition between a standard aerobic and resistance exercise training program and a shorter-duration, high-intensity CrossFit training program in overweight and obese physically inactive adults. Hypothe...
What is the current status of trial NCT02185872?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2012-02. Estimated completion is 2012-05.
What conditions does trial NCT02185872 study?
This clinical trial studies the following conditions: Hyperglycemia.
What interventions are being tested in trial NCT02185872?
The interventions under investigation include: High-Intensity Functional Training (OTHER), Aerobic and Resistance Training (OTHER).
Who is sponsoring clinical trial NCT02185872?
This trial is sponsored by Kansas State University, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02185872 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02185872's enrollment target sits among peer trials
23 31st of 38 higher than 8 of 38 other Hyperglycemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hyperglycemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
-
Time to Move in Pregnancy Hyperglycemia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia